PCSK9 VACCINE

The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogeni...

Full description

Saved in:
Bibliographic Details
Main Authors EISENBRAUN Michael Dale, MERSON James Richard, CHAMPION Brian Robert, CONTILLO Jr. Leonard Gabriel, ULLAH Jakir Hussain, PIERCE Brian Gregory, WYATT David Michael, HAWKINS Julie Jia Li, FRASER James Downey, QIU Xiayang
Format Patent
LanguageEnglish
Slovenian
Published 29.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
Bibliography:Application Number: SI20100031682T